{"id":"https://openalex.org/W2228089124","doi":"https://doi.org/10.1186/s12886-015-0178-9","title":"Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting","display_name":"Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting","publication_year":2016,"publication_date":"2016-01-05","ids":{"openalex":"https://openalex.org/W2228089124","doi":"https://doi.org/10.1186/s12886-015-0178-9","mag":"2228089124","pmid":"https://pubmed.ncbi.nlm.nih.gov/26728265","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4700741"},"language":"en","primary_location":{"id":"doi:10.1186/s12886-015-0178-9","doi":"https://doi.org/10.1186/s12886-015-0178-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12886-015-0178-9","pdf_url":"https://bmcophthalmol.biomedcentral.com/track/pdf/10.1186/s12886-015-0178-9","source":{"id":"https://openalex.org/S49440999","display_name":"BMC Ophthalmology","issn_l":"1471-2415","issn":["1471-2415"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcophthalmol.biomedcentral.com/track/pdf/10.1186/s12886-015-0178-9","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047967188","display_name":"Ibrahim Elaraoud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799762726","display_name":"New Cross Hospital","ror":"https://ror.org/05w3e4z48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799762726","https://openalex.org/I4210154310"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Ibrahim Elaraoud","raw_affiliation_strings":["Wolverhampton Eye Infirmary, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK. i_melaroud@hotmail.com","Wolverhampton Eye Infirmary, New Cross Hospital, Wolverhampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wolverhampton Eye Infirmary, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK. i_melaroud@hotmail.com","institution_ids":["https://openalex.org/I2799762726"]},{"raw_affiliation_string":"Wolverhampton Eye Infirmary, New Cross Hospital, Wolverhampton, UK","institution_ids":["https://openalex.org/I2799762726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071875587","display_name":"Walter Andreatta","orcid":"https://orcid.org/0000-0002-0563-6097","observed_orcids":["https://orcid.org/0000-0002-0563-6097"]},"institutions":[{"id":"https://openalex.org/I2799762726","display_name":"New Cross Hospital","ror":"https://ror.org/05w3e4z48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799762726","https://openalex.org/I4210154310"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Walter Andreatta","raw_affiliation_strings":["Wolverhampton Eye Infirmary, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK. walter.andreatta@uhb.nhs.uk","Wolverhampton Eye Infirmary, New Cross Hospital, Wolverhampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wolverhampton Eye Infirmary, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK. walter.andreatta@uhb.nhs.uk","institution_ids":["https://openalex.org/I2799762726"]},{"raw_affiliation_string":"Wolverhampton Eye Infirmary, New Cross Hospital, Wolverhampton, UK","institution_ids":["https://openalex.org/I2799762726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113600409","display_name":"Andrej Kidess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799307867","display_name":"Queen Elizabeth Hospital Birmingham","ror":"https://ror.org/048emj907","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049","https://openalex.org/I2799307867"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrej Kidess","raw_affiliation_strings":["Queen Elizabeth University Hospital Birmingham, Birmingham, B15 2TH, UK. andrea.kidress@uhb.nhs.uk","Queen Elizabeth University Hospital Birmingham, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Elizabeth University Hospital Birmingham, Birmingham, B15 2TH, UK. andrea.kidress@uhb.nhs.uk","institution_ids":["https://openalex.org/I2799307867"]},{"raw_affiliation_string":"Queen Elizabeth University Hospital Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I2799307867"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ajay Bhatnagar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799762726","display_name":"New Cross Hospital","ror":"https://ror.org/05w3e4z48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799762726","https://openalex.org/I4210154310"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ajay Bhatnagar","raw_affiliation_strings":["Wolverhampton Eye Infirmary, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK. ajay.bhatnagar@nhs.net","Wolverhampton Eye Infirmary, New Cross Hospital, Wolverhampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wolverhampton Eye Infirmary, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK. ajay.bhatnagar@nhs.net","institution_ids":["https://openalex.org/I2799762726"]},{"raw_affiliation_string":"Wolverhampton Eye Infirmary, New Cross Hospital, Wolverhampton, UK","institution_ids":["https://openalex.org/I2799762726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062927042","display_name":"Marie D. Tsaloumas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799307867","display_name":"Queen Elizabeth Hospital Birmingham","ror":"https://ror.org/048emj907","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049","https://openalex.org/I2799307867"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marie Tsaloumas","raw_affiliation_strings":["Queen Elizabeth University Hospital Birmingham, Birmingham, B15 2TH, UK","Queen Elizabeth University Hospital Birmingham, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Elizabeth University Hospital Birmingham, Birmingham, B15 2TH, UK","institution_ids":["https://openalex.org/I2799307867"]},{"raw_affiliation_string":"Queen Elizabeth University Hospital Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I2799307867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113688444","display_name":"Fahad Quhill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801732343","display_name":"Royal Hallamshire Hospital","ror":"https://ror.org/00514rc81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801732343","https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Fahad Quhill","raw_affiliation_strings":["Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK. fahdquhill@outlook.com","Royal Hallamshire Hospital, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK. fahdquhill@outlook.com","institution_ids":["https://openalex.org/I2801732343"]},{"raw_affiliation_string":"Royal Hallamshire Hospital, Sheffield, UK","institution_ids":["https://openalex.org/I2801732343"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009328256","display_name":"Yit Chiun Yang","orcid":"https://orcid.org/0000-0002-5392-5133","observed_orcids":["https://orcid.org/0000-0002-5392-5133"]},"institutions":[{"id":"https://openalex.org/I169199633","display_name":"Aston University","ror":"https://ror.org/05j0ve876","country_code":"GB","type":"education","lineage":["https://openalex.org/I169199633"]},{"id":"https://openalex.org/I2799762726","display_name":"New Cross Hospital","ror":"https://ror.org/05w3e4z48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799762726","https://openalex.org/I4210154310"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yit Yang","raw_affiliation_strings":["School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK. yit.yang@nhs.net","Wolverhampton Eye Infirmary, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK. yit.yang@nhs.net","School of Life and Health Sciences, Aston University, Birmingham, UK","Wolverhampton Eye Infirmary, New Cross Hospital, Wolverhampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK. yit.yang@nhs.net","institution_ids":["https://openalex.org/I169199633"]},{"raw_affiliation_string":"Wolverhampton Eye Infirmary, New Cross Hospital, Wednesfield Road, Wolverhampton, WV10 0QP, UK. yit.yang@nhs.net","institution_ids":["https://openalex.org/I2799762726"]},{"raw_affiliation_string":"School of Life and Health Sciences, Aston University, Birmingham, UK","institution_ids":["https://openalex.org/I169199633"]},{"raw_affiliation_string":"Wolverhampton Eye Infirmary, New Cross Hospital, Wolverhampton, UK","institution_ids":["https://openalex.org/I2799762726"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5047967188"],"corresponding_institution_ids":["https://openalex.org/I2799762726"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":7.0993,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.97383771,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"16","issue":"1","first_page":"3","last_page":"3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluocinolone-acetonide","display_name":"fluocinolone acetonide","score":0.9760000109672546},{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":0.9229999780654907},{"id":"https://openalex.org/keywords/pseudophakia","display_name":"pseudophakia","score":0.7149999737739563},{"id":"https://openalex.org/keywords/intravitreal-implant","display_name":"intravitreal implant","score":0.6729999780654907},{"id":"https://openalex.org/keywords/patient-selection-criteria","display_name":"patient selection criteria","score":0.8859999775886536},{"id":"https://openalex.org/keywords/nice-guidance","display_name":"NICE guidelines","score":0.6859999895095825},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.3659999966621399},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.7829999923706055},{"id":"https://openalex.org/keywords/central-retinal-thickness","display_name":"central retinal thickness","score":0.9309999942779541},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9791582822799683},{"id":"https://openalex.org/C2777463590","wikidata":"https://www.wikidata.org/wiki/Q924467","display_name":"Fluocinolone acetonide","level":2,"score":0.9786719083786011},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.7867209911346436},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47300630807876587},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.4354410171508789},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3745969831943512},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.28026634454727173},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17251357436180115},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.09267950057983398}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004343","descriptor_name":"Drug Implants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005446","descriptor_name":"Fluocinolone Acetonide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012160","descriptor_name":"Retina","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12886-015-0178-9","doi":"https://doi.org/10.1186/s12886-015-0178-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12886-015-0178-9","pdf_url":"https://bmcophthalmol.biomedcentral.com/track/pdf/10.1186/s12886-015-0178-9","source":{"id":"https://openalex.org/S49440999","display_name":"BMC Ophthalmology","issn_l":"1471-2415","issn":["1471-2415"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4700741","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4700741","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmol","raw_type":"Text"},{"id":"pmid:26728265","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26728265","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC ophthalmology","raw_type":"Journal Article"},{"id":"pmh:oai:publications.aston.ac.uk:29631","doi":null,"is_oa":true,"landing_page_url":"https://publications.aston.ac.uk/id/eprint/29631/1/Use_of_flucinolone_acetonide_for_patients_with_diabetic_macular_oedema.pdf","pdf_url":"https://publications.aston.ac.uk/id/eprint/29631/1/Use_of_flucinolone_acetonide_for_patients_with_diabetic_macular_oedema.pdf","source":{"id":"https://openalex.org/S4306400483","display_name":"Aston Publications Explorer (Aston University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169199633","host_organization_name":"Aston University","host_organization_lineage":["https://openalex.org/I169199633"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1186/s12886-015-0178-9","doi":"https://doi.org/10.1186/s12886-015-0178-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12886-015-0178-9","pdf_url":"https://bmcophthalmol.biomedcentral.com/track/pdf/10.1186/s12886-015-0178-9","source":{"id":"https://openalex.org/S49440999","display_name":"BMC Ophthalmology","issn_l":"1471-2415","issn":["1471-2415"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2228089124.pdf","grobid_xml":"https://content.openalex.org/works/W2228089124.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1782108791","https://openalex.org/W1786299986","https://openalex.org/W1809125639","https://openalex.org/W1980342089","https://openalex.org/W1989619939","https://openalex.org/W2020482183","https://openalex.org/W2042362462","https://openalex.org/W2049301829","https://openalex.org/W2104034463","https://openalex.org/W2111693183","https://openalex.org/W2138480916","https://openalex.org/W2145366413","https://openalex.org/W4240304626"],"related_works":["https://openalex.org/W2483754670","https://openalex.org/W2483906735","https://openalex.org/W2891133363","https://openalex.org/W4327681642","https://openalex.org/W2795092737","https://openalex.org/W2996066909","https://openalex.org/W1767546912","https://openalex.org/W757932465","https://openalex.org/W2960271241","https://openalex.org/W2600346569"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Fluocinolone":[1],"acetonide":[2],"slow":[3],"release":[4],"implant":[5],"(Iluvien\u00ae)":[6],"was":[7,32,47],"approved":[8],"in":[9,12,78,238],"December":[10],"2013":[11],"UK":[13],"for":[14,63],"treatment":[15,65,206],"of":[16,54,58,74,91,126,133,169,172],"eyes":[17,125,144,239],"which":[18,39,170,242],"are":[19],"pseudophakic":[20,124],"with":[21,95,138,240],"DMO":[22,241],"that":[23,81],"is":[24,51],"unresponsive":[25,84,192],"to":[26,85,107,193,203,221,246],"other":[27,249],"available":[28],"therapies.":[29],"This":[30,224],"approval":[31],"based":[33],"on":[34,56,60,69,218,232],"evidence":[35,231],"from":[36,226],"FAME":[37],"trials":[38],"were":[40,105,130,154,181],"conducted":[41],"at":[42,102,117],"a":[43,52],"time":[44,119],"when":[45],"ranibizumab":[46,86],"not":[48,244],"available.":[49],"There":[50],"paucity":[53],"data":[55,225],"implementation":[57],"guidance":[59,217],"selecting":[61],"patients":[62,80,93,129,134,165],"this":[64,227],"modality":[66],"and":[67,99,114,152,157,199,248],"also":[68,174],"the":[70],"real":[71],"world":[72],"outcome":[73],"fluocinolone":[75,96,204,219,236],"therapy":[76,137,237],"especially":[77],"those":[79],"have":[82],"been":[83],"therapy.":[87],"METHOD:":[88],"Retrospective":[89],"study":[90,228],"consecutive":[92,128],"treated":[94],"between":[97],"January":[98],"August":[100],"2014":[101],"three":[103],"sites":[104],"included":[106],"evaluate":[108],"selection":[109,212],"criteria":[110,213],"used,":[111],"baseline":[112,149],"characteristics":[113],"clinical":[115],"outcomes":[116,234],"3-month":[118],"point.":[120],"RESULTS:":[121],"Twenty":[122],"two":[123],"22":[127],"included.":[131],"Majority":[132],"had":[135,145,166,175,243],"prior":[136,195],"multiple":[139,194],"intravitreal":[140,250],"anti-VEGF":[141,200],"injections.":[142],"Four":[143],"controlled":[146],"glaucoma.":[147],"At":[148],"mean":[150],"VA":[151],"CRT":[153,168],"50.7":[155],"letters":[156],"631":[158],"\u03bcm":[159],"respectively.":[160],"After":[161],"3":[162],"months,":[163],"18":[164],"improved":[167,176],"15":[171],"them":[173],"VA.":[177],"No":[178],"adverse":[179],"effects":[180],"noted.":[182],"One":[183],"additional":[184],"patient":[185,210],"required":[186],"IOP":[187],"lowering":[188],"medication.":[189],"Despite":[190],"being":[191],"therapies":[196],"including":[197],"laser":[198,247],"injections,":[201],"switching":[202],"achieved":[205],"benefit.":[207],"CONCLUSION:":[208],"The":[209],"level":[211],"proposed":[214],"by":[215],"NICE":[216],"appeared":[220],"be":[222],"implemented.":[223],"provides":[229],"new":[230],"early":[233],"following":[235],"responded":[245],"agents.":[251]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}